CFG
TVTX icon

CKW Financial Group’s Travere Therapeutics TVTX Stock Holding History

CKW Financial Group’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Buy
+7
New +$310 ﹤0.01% 307

Other funds holding TVTX

SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
BC
Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

CKW Financial Group's TVTX Position: Q2 2026 in Review

CKW Financial Group opened a new position in Travere Therapeutics (TVTX) in Q2 2026: 7 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #307 among its holdings.

48 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.

  • CKW Financial Group held 7 shares of Travere Therapeutics worth $0 as of Q2 2026.
  • Travere Therapeutics was a new CKW Financial Group position in Q2 2026.
  • Travere Therapeutics made up ﹤0.01% of CKW Financial Group's portfolio in Q2 2026, its #307 holding.
  • 48 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.

Based on CKW Financial Group's 13F filing for Q2 2026, filed 27 Jul 2026.